513 related articles for article (PubMed ID: 18832247)
1. Hepatitis B virus infection.
Dienstag JL
N Engl J Med; 2008 Oct; 359(14):1486-500. PubMed ID: 18832247
[No Abstract] [Full Text] [Related]
2. Lamivudine useful against hepatitis B-HIV co-infection.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):34. PubMed ID: 11362610
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and B viruses: the new opportunists in HIV infection.
Chung RT
Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
Benhamou Y; Tubiana R; Thibault V
N Engl J Med; 2003 Jan; 348(2):177-8. PubMed ID: 12519935
[No Abstract] [Full Text] [Related]
5. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
6. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
Bottecchia M; Garcia-Samaniego J; Soriano V
Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G
AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
9. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution: bad or good factor in hepatitis B virus and HIV co-infection?
Perrella O; Sbreglia C; De Sena R; D'Antonio A; Perrella M; Cuomo O; Perrella A
AIDS; 2006 Mar; 20(5):790-1. PubMed ID: 16514319
[No Abstract] [Full Text] [Related]
12. Transmission of antiviral drug resistant hepatitis B virus: implications for public health and patient management.
Locarnini S
J Gastroenterol Hepatol; 2010 Apr; 25(4):649-51. PubMed ID: 20492319
[No Abstract] [Full Text] [Related]
13. In vitro models for studying hepatitis B virus drug resistance.
Zoulim F
Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
15. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report.
Johanson F
AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy.
Dore GJ
AIDS Read; 2004 Jul; 14(7):392. PubMed ID: 15282869
[No Abstract] [Full Text] [Related]
17. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
19. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
[No Abstract] [Full Text] [Related]
20. Hepatitis B virus: where are we and where are we going?
Manns MP; Hadem J; Wedemeyer H
Methods Mol Med; 2004; 96():415-43. PubMed ID: 14762285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
